healthŌme and Hannover Re Win 2024 Global Innovation Award for Genomics-Based Insurance Program
healthŌme and Hannover Re have won the 2024 Global Innovation Award in the Life | Health | Retirement category for their genomics-based insurance program. The award, presented by the International Insurance Society, Insurance Thought Leadership, and Lloyd's, recognizes their successful integration of genomics-based services into critical illness and life insurance products.
The program, distributed through Chubb Workplace Benefits as Cancer Advocate Plus, provides employees with DNA-based precision health insights, personalized medication optimization, and cancer management support. In 2025, the service will be available to individuals outside the workplace as Kadance Precision Health Management Program.
healthŌme e Hannover Re hanno vinto il Premio Globale per l'Innovazione 2024 nella categoria Vita | Salute | Previdenza per il loro programma assicurativo basato sulla genomica. Il premio, conferito dalla International Insurance Society, Insurance Thought Leadership e Lloyd's, riconosce la loro integrazione riuscita di servizi basati sulla genomica nei prodotti assicurativi per malattie gravi e vita.
Il programma, distribuito attraverso Chubb Workplace Benefits come Cancer Advocate Plus, fornisce ai dipendenti approfondimenti sulla salute di precisione basati sul DNA, ottimizzazione personalizzata dei medicinali e supporto nella gestione del cancro. Nel 2025, il servizio sarà disponibile per le persone al di fuori del posto di lavoro come Kadance Precision Health Management Program.
healthŌme y Hannover Re han ganado el Premio Global de Innovación 2024 en la categoría de Vida | Salud | Jubilación por su programa de seguros basado en genómica. El premio, presentado por la International Insurance Society, Insurance Thought Leadership y Lloyd's, reconoce su exitosa integración de servicios basados en genómica en productos de seguros de enfermedades críticas y vida.
El programa, distribuido a través de Chubb Workplace Benefits como Cancer Advocate Plus, proporciona a los empleados información de salud de precisión basada en ADN, optimización personalizada de medicamentos y apoyo en la gestión del cáncer. En 2025, el servicio estará disponible para individuos fuera del lugar de trabajo como Kadance Precision Health Management Program.
healthŌme와 Hannover Re가 2024년 글로벌 혁신상을 생명 | 건강 | 은퇴 부문에서 유전체 기반 보험 프로그램으로 수상했습니다. 이 상은 국제 보험 협회, 보험 사고 리더십 및 로이드에 의해 수여되며, 중증 질병 및 생명 보험 상품에 유전체 기반 서비스를 성공적으로 통합한 것을 인정받았습니다.
이 프로그램은 Chubb Workplace Benefits를 통해 Cancer Advocate Plus로 배포되며, 직원들에게 DNA 기반의 정밀 건강 통찰력, 개인 맞춤형 약물 최적화 및 암 관리 지원을 제공합니다. 2025년부터는 Kadance Precision Health Management Program으로 직장 외 개인에게도 제공될 예정입니다.
healthŌme et Hannover Re ont remporté le Prix Mondial de l'Innovation 2024 dans la catégorie Vie | Santé | Retraite pour leur programme d'assurance basé sur la génomique. Le prix, présenté par la Société Internationale des Assurances, Insurance Thought Leadership et Lloyd's, reconnaît leur intégration réussie des services basés sur la génomique dans les produits d'assurance de maladies graves et vie.
Le programme, distribué par Chubb Workplace Benefits sous le nom de Cancer Advocate Plus, offre aux employés des informations de santé de précision basées sur l'ADN, une optimisation personnalisée des médicaments et un soutien à la gestion du cancer. En 2025, le service sera disponible pour les personnes en dehors du milieu de travail sous le nom de Kadance Precision Health Management Program.
healthŌme und Hannover Re haben den Global Innovation Award 2024 in der Kategorie Leben | Gesundheit | Ruhestand für ihr geneomik-basiertes Versicherungsprogramm gewonnen. Der Preis, der von der International Insurance Society, Insurance Thought Leadership und Lloyd's verliehen wird, würdigt die erfolgreiche Integration genomik-basierter Dienstleistungen in Produkte für kritische Krankheiten und Lebensversicherungen.
Das Programm, das über Chubb Workplace Benefits als Cancer Advocate Plus vertrieben wird, bietet den Mitarbeitern DNA-basierte präzise Gesundheitsinformationen, personalisierte Medikamentenoptimierung und Unterstützung im Umgang mit Krebs. Im Jahr 2025 wird der Service auch für Personen außerhalb des Arbeitsplatzes als Kadance Precision Health Management Program verfügbar sein.
- Partnership with major insurers Hannover Re and Chubb expands market reach
- Recognition through prestigious industry award validates business model
- Planned expansion to individual market in 2025 opens new revenue streams
- Integration of genomics into insurance products creates competitive advantage
- None.
Award honors the integration of genomics into critical illness coverage, enhancing the value of life and critical illness products for insurers and policyholders.
"Receiving the 2024 Global Innovation Award is a testament to healthŌme's dedication to advancing personalized, genomics-driven healthcare," said Darren Rowe, CEO of healthŌme. "The support from Hannover Re, our reinsurer, and Chubb, our exclusive distribution partner in the worksite, has been vital in providing solutions that prioritize a proactive approach to health-first insurance-based programs that reshape how the industry serves members."
This award acknowledges the notable impact of healthŌme's precision health management program. With support from Hannover Re, healthŌme successfully integrated genomics-based services into critical illness and life insurance, delivering an innovative solution to the personal insurance market. This collaboration demonstrates how healthŌme and Hannover Re empower insurers to push boundaries, improve product offerings, and enhance member engagement. By providing groundbreaking living benefit solutions, they also strengthen policyholder relationships, improve brand equity for insurance carriers, and drive better policy persistency, creating lasting value for insurers and their customers.
"We're thrilled to receive this prestigious award, in collaboration with our partner healthŌme, that recognizes our commitment to advancing medical care for the treatment of cancer patients," said Steve Najjar, Executive Vice President, Head of Health Solutions and General Counsel at Hannover Life Reassurance Company of America. "This partnership allows us to leverage genomic-based technologies and life insurance solutions to enhance patient care and support individuals in living longer, healthier lives."
In partnership with Chubb, healthŌme's innovative services are distributed through Chubb Workplace Benefits as Cancer Advocate Plus. healthŌme provides employees access to proactive, DNA-based precision health insights, a personalized medication optimization plan, and tailored cancer management support. Pairing these services provided by healthŌme with the insurance benefits offered by Chubb, Cancer Advocate Plus is redefining insurance with health-first solutions.
"This benefits partnership exemplifies our focus on innovating and delivering value for our customers," said Alex Faynberg, Division President, Chubb Workplace Benefits. "It's a proactive and personalized approach to combining precision health insights with cancer management support. And we are honored to offer this program to our broker partners and clients."
The recognition by the IIS underscores the significant strides made by healthŌme and its partners in integrating advanced genomics into insurance products, delivering enhanced value, and enabling personalized care for policyholders. In 2025, the product will also be available for individuals to purchase outside the workplace as Kadance Precision Health Management Program, further expanding access to precision health and highlighting a shared commitment to driving innovation and excellence in insurance and healthcare.
About healthŌme, Inc.
healthŌme, Inc. is a genomics-based, precision health navigation company operating at the intersection of life insurance, life science, and health management. With a fully integrated, in-house genetics lab, healthŌme is dedicated to simplifying and accelerating access to technologies and services that can dramatically alter an individual's health trajectory, with an initial focus on cancer. healthŌme designs and delivers tech-enabled, precision health management solutions through a network of life and critical insurance carriers. healthŌme and its subsidiary, Kailos Genetics, are based at the HudsonAlpha Institute for Biotechnology in
About Hannover Re
Hannover Re is one of the world's leading reinsurers. It transacts all lines of property and casualty and life and health reinsurance and is present worldwide with more than 3,500 staff. German business of the Hannover Re Group is written by the subsidiary E+S Rück. Established in 1966, Hannover Re is recognized as a reliable partner for innovative risk solutions, exceptional customer intimacy and financial soundness. The rating agencies most relevant to the insurance industry have awarded both Hannover Re and E+S Rück outstanding financial strength ratings: Standard & Poor's AA- "Very Strong" and A.M. Best A+ "Superior".
About Chubb
Chubb is a world leader in insurance. With operations in 54 countries and territories, Chubb provides commercial and personal property and casualty insurance, personal accident and supplemental health insurance, reinsurance and life insurance to a diverse group of clients. The company is defined by its extensive product and service offerings, broad distribution capabilities, exceptional financial strength and local operations globally. Parent company Chubb Limited is listed on the New York Stock Exchange (NYSE: CB) and is a component of the S&P 500 index. Chubb employs approximately 40,000 people worldwide. Additional information can be found at: www.chubb.com.
View original content:https://www.prnewswire.com/news-releases/healthme-and-hannover-re-win-2024-global-innovation-award-for-genomics-based-insurance-program-302326945.html
SOURCE healthŌme, Inc.
FAQ
What award did healthŌme and Hannover Re win in 2024?
When will healthŌme's Kadance Precision Health Management Program launch for individual customers?
What services does healthŌme's Cancer Advocate Plus program provide through Chubb Workplace Benefits?
